Niagen Bioscience (NAGE) Amortizatization of Intangibles (2011 - 2026)
Niagen Bioscience (NAGE) reported Amortizatization of Intangibles of $175000.0 for Q1 2026, up 372.97% year-over-year from $37000.0 in Q1 2025, and up 191.67% quarter-over-quarter from $60000.0 in Q4 2025.
Niagen Bioscience (NAGE) Amortizatization of Intangibles (2011 - 2026) Analysis & Trends
Niagen Bioscience (NAGE) has 14 years of Amortizatization of Intangibles data on file, last reported at $175000.0 in Q1 2026.
- Amortizatization of Intangibles for Q1 2026 came in at $175000.0, up 372.97% year-over-year; the trailing twelve-month figure through Mar 2026 was $311000.0 (up 107.33% YoY), and the FY2025 annual result was $173000.0, up 14.57% from the prior year.
- Amortizatization of Intangibles climbed to $175000.0 in Q1 2026 per NAGE's latest filing, from $60000.0 in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $299000.0 in Q1 2022 and troughed at -$452000.0 in Q4 2022.
- A 5-year average of $49588.2 and a median of $39000.0 in 2023 frame the typical range for Amortizatization of Intangibles.
- On a YoY basis, Amortizatization of Intangibles climbed as much as 3480.0% in 2022 and fell as far as 986.27% in 2022.
- A 5-year view of Amortizatization of Intangibles shows it stood at -$452000.0 in 2022, then surged by 108.63% to $39000.0 in 2023, then slipped by 2.56% to $38000.0 in 2024, then soared by 57.89% to $60000.0 in 2025, then jumped by 191.67% to $175000.0 in 2026.
- Business Quant data shows NAGE's Amortizatization of Intangibles at $175000.0 in Q1 2026, $60000.0 in Q4 2025, and $38000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Niagen Bioscience | 277.31 Mn | 210.76 Mn | 19.98 Mn | 175,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 175,000.00 |
| Mar 31, 2026 | 175,000.00 |
| Dec 31, 2025 | 60,000.00 |
| Dec 31, 2025 | 60,000.00 |
| Sep 30, 2025 | 38,000.00 |
| Sep 30, 2025 | 38,000.00 |
| Jun 30, 2025 | 38,000.00 |
| Jun 30, 2025 | 38,000.00 |
| Mar 31, 2025 | 37,000.00 |
| Mar 31, 2025 | 37,000.00 |
| Dec 31, 2024 | 38,000.00 |
| Dec 31, 2024 | 38,000.00 |
| Sep 30, 2024 | 38,000.00 |
| Sep 30, 2024 | 38,000.00 |
| Jun 30, 2024 | 37,000.00 |
| Jun 30, 2024 | 37,000.00 |
| Mar 31, 2024 | 38,000.00 |
| Mar 31, 2024 | 38,000.00 |
| Dec 31, 2023 | 39,000.00 |
| Dec 31, 2023 | 39,000.00 |